Discovery of the Selective and Orally Available Galectin-1 Inhibitor GB1908 as a Potential Treatment for Lung Cancer.
Zetterberg FR, Peterson K, Nilsson UJ, Andréasson Dahlgren K, Diehl C, Holyer I, Håkansson M, Khabut A, Kahl-Knutson B, Leffler H, MacKinnon AC, Roper JA, Slack RJ, Zarrizi R, Pedersen A.
Zetterberg FR, et al. Among authors: khabut a.
J Med Chem. 2024 May 28. doi: 10.1021/acs.jmedchem.4c00485. Online ahead of print.
J Med Chem. 2024.
PMID: 38804039